Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Milos Mihajlovic, Sam Hariri, Koen C.G. Westphal, Manoe J. Janssen, Miriam J. Oost, Laura Bongiovanni, Lambertus P. van den Heuvel, Alain de Bruin, Luuk B. Hilbrands, Rosalinde Masereeuw
Published Sep 3, 2019 · Vol. 10, No. 51 · pp. 5332-5348
Luís Alberto de Pádua Covas Lage, Débora Levy, Flávia Dias Xavier, Diego Cândido Reis, Renata de Oliveira Costa, Marianne Castro Gonçalves, Vanderson Rocha, Maria Cláudia Nogueira Zerbini, Juliana Pereira
Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5136-5151
Sarabjot Pabla, Jonathan Andreas, Felicia L. Lenzo, Blake Burgher, Jacob Hagen, Vincent Giamo, Mary K. Nesline, Yirong Wang, Mark Gardner, Jeffrey M. Conroy, Antonios Papanicolau-Sengos, Carl Morrison, Sean T. Glenn
Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5181-5193
Catrin Tauber, Michael Schultheiss, Raffaele De Luca, Nico Buettner, Sian Llewellyn-Lacey, Florian Emmerich, Sebastian Zehe, David A. Price, Christoph Neumann-Haefelin, Annette Schmitt-Graeff, Maike Hofmann, Robert Thimme
Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5194-5206